Compelling data have reported that some major suppressors are involved in pancreatic carcinogenesis, such as p16, Tp53 and Smad4. However, the vehicle that permits early diagnosis or effective treatment for pancreatic cancer is limited. This evidence concerns the gene SMAD4 and pancreatic neoplasm.